Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Cancer|September 19, 2002
A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neckRoy B Tishler, Charles M Norris, A Dimitrios Colevas, et al.
Head & Neck|December 20, 2021
Oligometastatic adenoid cystic carcinoma: Correlating tumor burden and time to treatment with outcomesKevin Tyan, Ji Eun Bae, Jochen H Lorch, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2006
Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neckRoy B Tishler, Marshall R Posner, Charles M Norris, et al.
Cancer Biomarkers : Section a of Disease Markers|April 8, 2017
Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinomaGlenn J Hanna, Vishwajith Sridharan, Danielle N Margalit, et al.
The Oncologist|April 21, 2020
The Benefits of Adjuvant Trastuzumab for HER-2-Positive Salivary Gland CancersGlenn J Hanna, Ji Eun Bae, Jochen H Lorch, et al.
Cancer|October 19, 2021
Exposed bone in patients with head and neck cancer treated with radiation therapy: An analysis of the Observational Study of Dental Outcomes in Head and Neck Cancer Patients (OraRad)Nathaniel S Treister, Michael T Brennan, Thomas P Sollecito, et al.
British Journal of Cancer|July 6, 2016
Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancerVishwajith Sridharan, Danielle N Margalit, Stephanie A Lynch, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2008
Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapyHale B Caglar, Roy B Tishler, Megan Othus, et al.
Frontiers in Oncology|March 14, 2019
Everolimus in Anaplastic Thyroid Cancer: A Case SeriesEthan J Harris, Glenn J Hanna, Nicole Chau, et al.
Oral Oncology|October 1, 2016
Patterns of failure after reirradiation with intensity-modulated radiation therapy and the competing risk of out-of-field recurrencesDanielle N Margalit, Bhupendra Rawal, Paul J Catalano, et al.
Pageof 10